Pages that link to "Q45861736"
Jump to navigation
Jump to search
The following pages link to Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. (Q45861736):
Displaying 50 items.
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q24198270) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q24202357) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q24245035) (← links)
- Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation (Q24624885) (← links)
- Taking stock of gene therapy for cystic fibrosis (Q24791317) (← links)
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease (Q26471459) (← links)
- New and emerging targeted therapies for cystic fibrosis (Q26749278) (← links)
- Gene therapy: light is finally in the tunnel (Q27000091) (← links)
- Cystic fibrosis (Q28212180) (← links)
- Recent advances in cystic fibrosis (Q28367361) (← links)
- Cytokines as biomarkers of nanoparticle immunotoxicity (Q28383550) (← links)
- Barriers to inhaled gene therapy of obstructive lung diseases: A review (Q29248141) (← links)
- Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data (Q30784080) (← links)
- Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit (Q30892610) (← links)
- Laser fluorescence bronchoscopy for detection of fluorescent reporter genes in airway epithelia (Q33185135) (← links)
- Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display (Q33208315) (← links)
- Nanodelivery in airway diseases: challenges and therapeutic applications (Q33483926) (← links)
- Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies (Q33664918) (← links)
- Self-assembled lipid nanomedicines for siRNA tumor targeting. (Q33907953) (← links)
- In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers (Q33914869) (← links)
- Current status of gene therapy for cystic fibrosis pulmonary disease (Q33975113) (← links)
- Emerging treatments in cystic fibrosis (Q34019357) (← links)
- Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium. (Q34064665) (← links)
- The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways (Q34106600) (← links)
- Flexible bronchoscopy in molecular biology (Q34302940) (← links)
- Viral and nonviral delivery systems for gene delivery (Q34315475) (← links)
- The challenge of gene therapy and DNA delivery (Q34385675) (← links)
- Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. (Q34483772) (← links)
- Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. (Q34496721) (← links)
- Electroporation-mediated gene delivery of Na+,K+ -ATPase, and ENaC subunits to the lung attenuates acute respiratory distress syndrome in a two-hit porcine model. (Q34725627) (← links)
- Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer (Q34943604) (← links)
- Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose (Q34974119) (← links)
- Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. (Q35012413) (← links)
- In vivo characteristics of cationic liposomes as delivery vectors for gene therapy (Q35012639) (← links)
- AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects (Q35027496) (← links)
- Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies (Q35043552) (← links)
- Current status of gene therapy for inherited lung diseases (Q35043830) (← links)
- Aerosol gene therapy (Q35075194) (← links)
- Designing of 'intelligent' liposomes for efficient delivery of drugs. (Q35075383) (← links)
- Immunological hurdles to lung gene therapy. (Q35091006) (← links)
- Non-viral gene transfer therapy for cystic fibrosis (Q35144032) (← links)
- Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis (Q35557791) (← links)
- Clinical review: gene-based therapies for ALI/ARDS: where are we now? (Q35558172) (← links)
- Clinical gene therapy for nonmalignant disease (Q35576409) (← links)
- Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury (Q35600453) (← links)
- Emerging drug treatments for cystic fibrosis (Q35602683) (← links)
- Delivery systems for pulmonary gene therapy (Q35627914) (← links)
- Cystic Fibrosis Gene Therapy in the UK and Elsewhere (Q35641704) (← links)
- Toward the pharmacogenomics of cystic fibrosis--an update. (Q35911156) (← links)
- Novel molecular approaches to cystic fibrosis gene therapy (Q36012920) (← links)